Acute Erythroid Leukemia: Clinical Trials

3 trials for Acute Erythroid Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 terminated. 3 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Active not recruiting 1, Completed 1, Terminated 1
Phase 12Active not recruiting 1, Completed 1

Follow Acute Erythroid Leukemia: new trials by email Literature Review of Acute Erythroid Leukemia trials Research Report on Acute Erythroid Leukemia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers
Fludarabine, Cyclophosphamide, Thiotepa - Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia
Phase 2TerminatedFred Hutchinson Cancer Center12022-10-062025-01-01
Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies
Aldesleukin, Allogeneic CD56-positive CD3-negative Natural Killer Cells, Allogeneic Hematopoietic Stem Cell Transplantation - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia
Phase 1 / Phase 2CompletedM.D. Anderson Cancer Center632013-06-112023-11-07
Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Azacitidine, Laboratory Biomarker Analysis, Pharmacological Study - Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia
Phase 1 / Phase 2Active not recruitingNational Cancer Institute (NCI)1352006-11-222026-08-07

Narrower conditions

Leukemia, Erythroblastic, Acute (3)  ·  Leukemia, Megakaryoblastic, Acute (3)  ·  Leukemia, Myeloid, Acute (3)  ·  Myelodysplastic Syndromes (3)  ·  Anemia, Refractory (2)  ·  Anemia, Refractory, with Excess of Blasts (2)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2)  ·  Leukemia, Myelomonocytic, Chronic (2)  ·  Blast Crisis (1)  ·  HIV Infections (1)  ·  Hematologic Neoplasms (1)  ·  Leukemia, Myeloid, Accelerated Phase (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Bone Marrow Diseases (3)  ·  Chronic Disease (3)  ·  Disease Attributes (3)  ·  Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Leukemia (3)  ·  Leukemia, Myeloid (3)  ·  Myeloproliferative Disorders (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Anemia (2)  ·  Myelodysplastic-Myeloproliferative Diseases (2)  ·  Blood-Borne Infections (1)

Interventions

fludarabine phosphate (2)  ·  Azacitidine (1)  ·  Busulfan (1)  ·  Cord Blood Stem Cell Transplantation (1)  ·  Cyclophosphamide (1)  ·  Peripheral Blood Stem Cell Transplantation (1)  ·  Thiotepa (1)  ·  Vorinostat (1)  ·  Whole-Body Irradiation (1)  ·  aldesleukin (1)  ·  fludarabine (1)

Sponsors

Fred Hutchinson Cancer Center (1)  ·  M.D. Anderson Cancer Center (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (3)

Top investigators

Filippo Milano (1)  ·  Lewis R Silverman (1)  ·  Richard E Champlin (1)

NIH funding

N01CM17103 (1), N01CM62204 (1), P30CA013330 (1), R34HL142322 (1)